NO960724D0 - Middel for transdermal applisering inneholdende gestodenestere - Google Patents

Middel for transdermal applisering inneholdende gestodenestere

Info

Publication number
NO960724D0
NO960724D0 NO960724A NO960724A NO960724D0 NO 960724 D0 NO960724 D0 NO 960724D0 NO 960724 A NO960724 A NO 960724A NO 960724 A NO960724 A NO 960724A NO 960724 D0 NO960724 D0 NO 960724D0
Authority
NO
Norway
Prior art keywords
gestoden
esters
transdermal application
application containing
transdermal
Prior art date
Application number
NO960724A
Other languages
English (en)
Other versions
NO960724L (no
Inventor
Ralph Lipp
Henry Laurent
Clemens Gunther
Jutta Riedl
Peter Esperling
Ulrich Tauber
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO960724L publication Critical patent/NO960724L/no
Publication of NO960724D0 publication Critical patent/NO960724D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
NO960724A 1993-08-26 1996-02-23 Middel for transdermal applisering inneholdende gestodenestere NO960724D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4329242A DE4329242A1 (de) 1993-08-26 1993-08-26 Mittel zur transdermalen Applikation enthaltend Gestodenester
PCT/EP1994/002496 WO1995005827A1 (de) 1993-08-26 1994-07-29 Mittel zur transdermalen applikation enthaltend gestodenester

Publications (2)

Publication Number Publication Date
NO960724L NO960724L (no) 1996-02-23
NO960724D0 true NO960724D0 (no) 1996-02-23

Family

ID=6496410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960724A NO960724D0 (no) 1993-08-26 1996-02-23 Middel for transdermal applisering inneholdende gestodenestere

Country Status (10)

Country Link
US (1) US5858394A (no)
EP (1) EP0715518A1 (no)
JP (1) JPH09504783A (no)
AU (1) AU693802B2 (no)
CA (1) CA2170371A1 (no)
DE (1) DE4329242A1 (no)
FI (1) FI960800A (no)
HU (1) HUT73236A (no)
NO (1) NO960724D0 (no)
WO (1) WO1995005827A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US6540332B2 (en) * 1997-07-15 2003-04-01 Silverbrook Research Pty Ltd Motion transmitting structure for a nozzle arrangement of a printhead chip for an inkjet printhead
US6846496B1 (en) 1999-10-15 2005-01-25 Orion Corporation Treatment of osteoporosis
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US7330822B1 (en) * 2001-05-29 2008-02-12 Oracle International Corporation Methods and systems for managing hierarchically organized and interdependent tasks and issues
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
US6652020B2 (en) * 2002-04-09 2003-11-25 Norco Industries, Inc. Reinforcing bracket for trailer-frame butt joints
SI1594483T1 (sl) * 2003-02-21 2006-12-31 Schering Ag UV-stabilni transdermalni terapevtski obliz
BRPI0417530B8 (pt) * 2003-12-12 2021-05-25 Bayer Ip Gmbh composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US7468470B2 (en) 2004-03-26 2008-12-23 Schering Ag Medicinal patch that leaves less adhesive residue when removed
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546062A1 (de) * 1975-10-10 1977-04-21 Schering Ag Delta hoch 15 -steroide
US4081537A (en) * 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
JPH06502419A (ja) * 1990-10-29 1994-03-17 アルザ・コーポレーション 経皮避妊製剤、方法及びデバイス
JPH0650974A (ja) * 1992-07-29 1994-02-25 Nec Corp 免疫センサシステムおよびこれを用いた免疫測定方法

Also Published As

Publication number Publication date
HU9503654D0 (en) 1996-02-28
EP0715518A1 (de) 1996-06-12
FI960800A0 (fi) 1996-02-22
NO960724L (no) 1996-02-23
FI960800A (fi) 1996-02-22
AU693802B2 (en) 1998-07-09
US5858394A (en) 1999-01-12
CA2170371A1 (en) 1995-03-02
HUT73236A (en) 1996-07-29
AU7533694A (en) 1995-03-21
WO1995005827A1 (de) 1995-03-02
DE4329242A1 (de) 1995-03-02
JPH09504783A (ja) 1997-05-13

Similar Documents

Publication Publication Date Title
NO960724D0 (no) Middel for transdermal applisering inneholdende gestodenestere
DE69431209T2 (de) Transdermale prostaglandin-zusammensetzung
DK0685105T3 (da) Holder til CD
FI931736A0 (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
FI960165A (fi) Säädetty apoptoosi
DE69426402D1 (de) Photothermographische Materialien
DE69411222T2 (de) Schmalbundiges Mach-Zehnder Filter
DE9311467U1 (de) Abstützvorrichtung
NO955229D0 (no) Fjernmåle-styresystem
BR9403908A (pt) Dispositivo de apoio
BR9403900A (pt) Dispositivo de apoio
DE69301600D1 (de) Photothermographische Materialien
DE69427178T2 (de) Modulatoren
NO932040D0 (no) Varslingsanordning for taksluk
DK0697850T3 (da) Klæbemiddel til tandproteser
DK33093A (da) Holder til diske
DE9316675U1 (de) Geräte zum Anhängen von Hebezeugen
KR950001439U (ko) 전주 지지대
DE9309587U1 (de) Stütze
KR950016467U (ko) 지지장치
FI96140C (fi) Nopea hiilidioksidiherkkä mikroelektrodi
ITVE930007A0 (it) Allestimento per esposizione
BR7302061U (pt) Suporte de penachos
BR7300553U (pt) Suporte
BR9301986A (pt) Suporte

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application